ArticleBritish journal of pharmacology2012

Characterization of DDRI-18 (3,3'-(1H,3'H-5,5'-bibenzo[d]imidazole-2,2'-diyl)dianiline), a novel small molecule inhibitor modulating the DNA damage response.

D W Jun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.